10/05/2024  17:31:10 Chg. +1.78 Volume Bid21:52:19 Demandez à21:52:19 Capitalisation boursière Dividende Y. Rapport P/E
92.32CHF +1.97% 3.23 Mio.
Chiffrre d'affaires: 297.62 Mio.
-Bid taille: 210 -Ask la taille: 2,590 210.09 Mrd.CHF - -

Description de l'entreprise

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic and biosimilar pharmaceuticals and eye care. Novartis has leading positions globally in each of these areas. Novartis products are sold in approximately 155 countries around the world.
 

Conseil d'administration & Conseil de surveillance

PDG
Vasant Narasimhan, M.D.
Conseil d'administration
Harry Kirsch, Dr. Klaus Moosmayer, Dr. Steffen Lang, Karen L. Hale, Marie-France Tschudin, Rob Kowalski, Shreeram Aradhye, Victor Bulto, Aharon (Ronny) Gal, Dr. Fiona H. Marshall
Conseil de surveillance
Dr. Joerg Reinhardt, Bridgette Heller, Charles L. Sawyers, M.D., Dr. Charlotte Pamer-Wieser, Dr. Nancy C. Andrews, Elizabeth Doherty, Frans van Houten, Patrice Bula, Simon Moroney, Ton Buechner, William T. Winters, Daniel Hochstrasser, Ana de Pro Gonzalo, John D. Young
 

Données de l'entreprise

Nom: Novartis AG
Adresse: Lichtstrasse 35,CH-4002 Basel
Téléphone: +41-61-324-1111
Fax: +41-61-324-8001
Courriel: -
Internet: www.novartis.com
Industrie: Healthcare
Secteur: Pharmaceutical Industry
Sous-secteur: Pharmaceuticals
Fin de l'exercice financier: 31/12
Flotte libre: 86.85%
IPO date: 07/03/1996

Relations avec les investisseurs

Nom: Imke Kappes
Téléphone IR: +41 61 324 8269
IR-Fax: -
E-mail IR: investor.relations@n...tis.com investor.relations@novartis.com

Principaux actionnaires

Autres
 
54.16%
Morgan Stanley
 
32.00%
Novartis AG
 
7.18%
Sandoz Family Foundation
 
3.71%
Dodge & Cox Inc
 
0.72%
Primecap Management Company
 
0.66%
Loomis Sayles & Company, LP
 
0.28%
Franklin Resources, Inc.
 
0.27%
Dimensional Fund Advisors LP
 
0.27%
Autres
 
0.75%